Effects of treatment modalities for Graves' hyperthyroidism on Graves' orbitopathy: a 2015 Italian Society of Endocrinology Consensus Statement. [PDF]
Bartalena L +4 more
core +1 more source
Quantitative intravoxel incoherent motion diffusion-weighted imaging histogram profiling identifies diffusion biomarkers for active thyroid-associated ophthalmopathy. [PDF]
Li D, Zhang N, Wang Y, Zhu T.
europepmc +1 more source
Patients with autoimmune thyroid diseases have antibodies to plasmid encoded proteins of enteropathogenic Yersinia [PDF]
Heesemann, Jürgen +3 more
core +3 more sources
Application progress of magnetic resonance imaging in thyroid associated ophthalmopathy. [PDF]
Song Y +6 more
europepmc +1 more source
Choroidal profile in patients with inactive thyroid-associated ophthalmopathy. [PDF]
Samadi M +7 more
europepmc +1 more source
Thyrotropin and IgG from patients with Graves' disease induce class-II antigen on human thyroid cells [PDF]
Drexhage, H. A. +5 more
core
Optimal timing for cataract surgery in patients with thyroid-associated ophthalmopathy. [PDF]
Miao N, Chen YC, He WM.
europepmc +1 more source
Gypenosides attenuate H<sub>2</sub>O<sub>2</sub>-induced oxidative stress in orbital fibroblasts from thyroid-associated ophthalmopathy by activating the Nrf2/ERK/HO-1 signaling pathway. [PDF]
Ma C +6 more
europepmc +1 more source
Cerium oxide nanoparticles attenuates fibrosis and inflammation in thyroid-associated ophthalmopathy via JNK pathway. [PDF]
Wang BW +5 more
europepmc +1 more source
A novel nomogram based on orbital MRI parameters for early prediction of dysthyroid optic neuropathy in thyroid-associated ophthalmopathy. [PDF]
Zhao X, Li Y, Lu Y, Liu M, Li Z.
europepmc +1 more source

